Nothing Special   »   [go: up one dir, main page]

HK1208497A1 - Method of establishing modified host cell - Google Patents

Method of establishing modified host cell

Info

Publication number
HK1208497A1
HK1208497A1 HK15109168.0A HK15109168A HK1208497A1 HK 1208497 A1 HK1208497 A1 HK 1208497A1 HK 15109168 A HK15109168 A HK 15109168A HK 1208497 A1 HK1208497 A1 HK 1208497A1
Authority
HK
Hong Kong
Prior art keywords
host cell
modified host
establishing
establishing modified
cell
Prior art date
Application number
HK15109168.0A
Other languages
Chinese (zh)
Inventor
Hisahiro Tabuchi
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of HK1208497A1 publication Critical patent/HK1208497A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering N.A.
    • C12N2310/141MicroRNAs, miRNAs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/50Biochemical production, i.e. in a transformed host cell
    • C12N2330/51Specially adapted vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK15109168.0A 2012-10-10 2015-09-18 Method of establishing modified host cell HK1208497A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012225537 2012-10-10
PCT/JP2013/077629 WO2014058025A1 (en) 2012-10-10 2013-10-10 Method of establishing modified host cell

Publications (1)

Publication Number Publication Date
HK1208497A1 true HK1208497A1 (en) 2016-03-04

Family

ID=50477491

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15109168.0A HK1208497A1 (en) 2012-10-10 2015-09-18 Method of establishing modified host cell

Country Status (9)

Country Link
US (1) US11608508B2 (en)
EP (1) EP2921554B1 (en)
JP (2) JP6463634B2 (en)
KR (2) KR102213583B1 (en)
CN (2) CN104718291B (en)
HK (1) HK1208497A1 (en)
SG (1) SG11201502801RA (en)
TW (2) TWI642779B (en)
WO (1) WO2014058025A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202340452A (en) * 2015-08-04 2023-10-16 美商再生元醫藥公司 Taurine supplemented cell culture medium and methods of use
EP3390653B1 (en) * 2015-12-16 2022-08-10 F. Hoffmann-La Roche AG Improved recombinant production method
US11261462B2 (en) 2016-01-27 2022-03-01 Just-Evotec Biologics, Inc. Inducible expression from transposon-based vectors and uses
US11098310B2 (en) 2016-01-27 2021-08-24 Just-Evotec Biologics, Inc. Expression from transposon-based vectors and uses
WO2017132376A1 (en) * 2016-01-27 2017-08-03 Just Biotherapeutics, Inc. Hybrid promoter and uses thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW402639B (en) 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US7794931B2 (en) * 2002-09-20 2010-09-14 Yale University Riboswitches, methods for their use, and compositions for use with riboswitches
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
CN1842540B (en) 2004-07-09 2012-07-04 中外制药株式会社 Anti-glypican 3 antibody
WO2007119774A1 (en) 2006-04-13 2007-10-25 Chugai Seiyaku Kabushiki Kaisha Taurine transporter gene
WO2008114673A1 (en) * 2007-03-15 2008-09-25 Chugai Seiyaku Kabushiki Kaisha Method for production of polypeptide
EP2167138A2 (en) * 2007-06-08 2010-03-31 Asuragen, INC. Mir-34 regulated genes and pathways as targets for therapeutic intervention
ES2591284T3 (en) 2007-08-07 2016-11-25 Chugai Seiyaku Kabushiki Kaisha Method for the production of heterogeneous proteins
WO2009051109A1 (en) 2007-10-15 2009-04-23 Chugai Seiyaku Kabushiki Kaisha Method of constructing cells with high productivity of foreign protein
WO2009054433A1 (en) 2007-10-24 2009-04-30 Chugai Seiyaku Kabushiki Kaisha Cell for use in the production of exogenous protein, and production process using the cell
DE102008035152A1 (en) * 2008-07-28 2010-02-04 Evocatal Gmbh Chaperone toolbox
JP2011082002A (en) 2009-10-07 2011-04-21 Stanley Electric Co Ltd Projector-type head light and shading device
JP2012055303A (en) * 2010-08-12 2012-03-22 Toyobo Co Ltd Expression vector for establishment of highly productive cell including gene amplification
SG194014A1 (en) * 2011-04-01 2013-11-29 Chugai Pharmaceutical Co Ltd Recombinant polypeptide production method

Also Published As

Publication number Publication date
CN104718291B (en) 2020-12-01
EP2921554A1 (en) 2015-09-23
KR102358375B1 (en) 2022-02-08
JP6463634B2 (en) 2019-02-06
US20150275230A1 (en) 2015-10-01
CN104718291A (en) 2015-06-17
EP2921554B1 (en) 2019-12-04
KR102213583B1 (en) 2021-02-09
US11608508B2 (en) 2023-03-21
TW201439319A (en) 2014-10-16
TWI692526B (en) 2020-05-01
JPWO2014058025A1 (en) 2016-09-05
KR20210014223A (en) 2021-02-08
TWI642779B (en) 2018-12-01
TW201903153A (en) 2019-01-16
SG11201502801RA (en) 2015-06-29
CN112522353A (en) 2021-03-19
JP2019022508A (en) 2019-02-14
WO2014058025A1 (en) 2014-04-17
KR20150065812A (en) 2015-06-15
EP2921554A4 (en) 2016-06-29
JP6680848B2 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
ZA201502433B (en) Methods of host cell modification
IL244791A0 (en) Methods of host cell modification
PL2825719T3 (en) Method of well operation
EP2859123A4 (en) Method of sequence determination using sequence tags
GB2512429B (en) Method of printing
GB201222693D0 (en) Novel method
GB2512430B (en) Method of printing
PL2809816T3 (en) Expression method
EP2880048A4 (en) Method
HK1208497A1 (en) Method of establishing modified host cell
GB201220155D0 (en) Method of manufacture
GB201202198D0 (en) Method
ZA201503410B (en) Method of making alpha, omega-diiodoperfluoroalkanes
EP2928294A4 (en) Cell preparation method
EP2845678A4 (en) Electrode tip-grinding method
GB2510694B (en) Method of printing
GB2510695B (en) Method of printing
GB201215942D0 (en) Method of treatent
GB2510693B (en) Method of printing
GB201220282D0 (en) Electrochemical method
GB201203337D0 (en) Method
GB201201332D0 (en) Method
EP2639418A4 (en) Exhaust-heating method
ZA201503833B (en) Method of hemoglobin-f determination
GB2510486B (en) Method of printing